It felt like a VERY long bow to pull, indeed (but at least he did admit he was guessing).
I think it could just as easily be that MSB issued the release ON ITS OWN--perhaps even as a way to chivvy Novartis along. None of us have seen the agreement, so don't know what terms prevail before Novartis well and truly crap off get off the pot. I don't see MSB tying its hands so tightly that it is prevented from merely issuing a non-price sensitive announcement re: issuance of a peer-reviewed publication unless Novartis gives them the okay.
Moderated, page-16
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |